Authors:
Hedstrom, J
Haglund, C
Leinonen, J
Nordling, S
Stenman, UH
Citation: J. Hedstrom et al., Trypsinogen-1,-2 and tumour-associated trypsin-inhibitor in bile and biliary tract tissues from patients with biliary tract diseases and pancreatic carcinomas, SC J CL INV, 61(2), 2001, pp. 111-118
Authors:
Karhumaa, P
Leinonen, J
Parkkila, S
Kaunisto, K
Tapanainen, J
Rajaniemi, H
Citation: P. Karhumaa et al., The identification of secreted carbonic anhydrase VI as a constitutive glycoprotein of human and rat milk, P NAS US, 98(20), 2001, pp. 11604-11608
Authors:
Hakama, M
Stenman, UH
Aromaa, A
Leinonen, J
Hakulinen, T
Knekt, P
Citation: M. Hakama et al., Validity of the prostate specific antigen test for prostate cancer screening: Followup study with a bank of 21,000 sera in Finland, J UROL, 166(6), 2001, pp. 2189-2191
Authors:
Leinonen, J
Parkkila, S
Kaunisto, K
Koivunen, P
Rajaniemi, H
Citation: J. Leinonen et al., Secretion of carbonic anhydrase isoenzyme VI (CA VI) from human and rat lingual serous von Ebner's glands, J HIST CYTO, 49(5), 2001, pp. 657-662
Citation: J. Leinonen et Uh. Stenman, Reduced stability of prostate-specific antigen after long-term storage of serum at-20 degrees C, TUMOR BIOL, 21(1), 2000, pp. 46-53
Citation: Wm. Zhang et al., Determination of prostate-specific antigen complexed to alpha(2)-macroclobulin in serum increases the specificity of free to total PSA for prostate cancer, UROLOGY, 56(2), 2000, pp. 267-272
Authors:
Zhang, WM
Finne, P
Leinonen, J
Stenman, UH
Citation: Wm. Zhang et al., Characterization and determination of the complex between prostate-specific antigen and alpha(1)-protease inhibitor in benign and malignant prostaticdiseases, SC J CL INV, 60, 2000, pp. 51-58
Authors:
Leinonen, J
Wu, P
Koivunen, E
Narvanen, A
Stenman, UH
Citation: J. Leinonen et al., Development of novel peptide ligands modulating the enzyme activity of prostate-specific antigen, SC J CL INV, 60, 2000, pp. 59-64
Authors:
Finne, P
Zhang, WM
Auvinen, A
Leinonen, J
Maattanen, L
Rannikko, S
Tammela, TLJ
Stenman, UH
Citation: P. Finne et al., Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer, J UROL, 164(6), 2000, pp. 1956-1960
Authors:
Wu, P
Leinonen, J
Koivunen, E
Lankinen, H
Stenman, UH
Citation: P. Wu et al., Identification of novel prostate-specific antigen-binding peptides modulating its enzyme activity, EUR J BIOCH, 267(20), 2000, pp. 6212-6220
Authors:
Stenman, UH
Paus, E
Allard, WJ
Andersson, I
Andres, C
Barnett, TR
Becker, C
Belenky, A
Bellanger, L
Pellegrino, CM
Bormer, OP
Davis, G
Dowell, B
Grauer, LS
Jette, DC
Karlsson, B
Kreutz, FT
van der Kwast, TM
Lauren, L
Leinimaa, M
Leinonen, J
Lilja, H
Linton, HJ
Nap, M
Nilsson, O
Ng, PC
Nustad, K
Peter, A
Pettersson, K
Piironen, T
Rapp, J
Rittenhouse, HG
Rye, PD
Seguin, P
Slota, J
Sokoloff, RL
Suresh, MR
Very, DL
Wang, TJ
Wigheden, I
Wolfert, RL
Yeung, KK
Zhang, WM
Zhou, Z
Hilgers, J
Citation: Uh. Stenman et al., Summary report of the TD-3 workshop: Characterization of 83 antibodies against prostate-specific antigen, TUMOR BIOL, 20, 1999, pp. 1-12
Authors:
Leinonen, J
Zhang, WM
Paus, E
Stenman, UH
Citation: J. Leinonen et al., Reactivity of 77 antibodies to prostate-specific antigen with isoenzymes and complexes of prostate-specific antigen, TUMOR BIOL, 20, 1999, pp. 28-34
Authors:
Zhang, WM
Finne, P
Leinonen, J
Vesalainen, S
Nordling, S
Stenman, UH
Citation: Wm. Zhang et al., Measurement of the complex between prostate-specific antigen and alpha(1)-protease inhibitor in serum, CLIN CHEM, 45(6), 1999, pp. 814-821
Citation: Mh. Black et al., Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays, CLIN CHEM, 45(3), 1999, pp. 347-354
Authors:
Hedstrom, J
Haglund, C
Kemppainen, E
Leinimaa, M
Leinonen, J
Stenman, UH
Citation: J. Hedstrom et al., Time-resolved immunofluorometric assay of trypsin-I complexed with alpha(1)-antitrypsin in serum: Increased immunoreactivity in patients with biliarytract cancer, CLIN CHEM, 45(10), 1999, pp. 1768-1773
Authors:
Leinonen, J
Rantalaiho, V
Lehtimaki, T
Koivula, T
Wirta, O
Pasternack, A
Alho, H
Citation: J. Leinonen et al., The association between the total antioxidant potential of plasma and the presence of coronary heart disease and renal dysfunction in patients with NIDDM, FREE RAD RE, 29(4), 1998, pp. 273-281
Authors:
Zhang, WM
Finne, P
Leinonen, J
Vesalainen, S
Nordling, S
Rannikko, S
Stenman, UH
Citation: Wm. Zhang et al., Characterization and immunological determination of the complex between prostate-specific antigen and alpha(2)-macroglobulin, CLIN CHEM, 44(12), 1998, pp. 2471-2479